Bloomberg GSK Plc and CureVac NV are planning further patient trials of their messenger RNA vaccines for flu and Covid-19 after promising early results, though the partners still lag behind rivals in the race to expand use of mRNA technology. The partners’ second-generation vaccine candidates showed promising abilities to spur the immune system in early-stage trials, CureVac said. The ...

Bloomberg Euro-area inflation returned to single digits for the first time since August, fuelling hopes that the bloc’s worst-ever spike in consumer prices has peaked. December’s reading came in at 9.2%, Eurostat said, with slower growth in energy costs the only reason for the moderation. The figure reflects slowdowns in Germany, France, Italy and Spain and was less than the ...

  Bloomberg China’s equities are poised to claim back a one-third weighting in a benchmark emerging-markets index, following a sharp outperformance sparked by an easing of strict Covid-19 curbs and a pivot to pro-growth policies. Stocks listed in the mainland and Hong Kong now account for 32.2% of the MSCI Emerging Markets Index, up from 26.8% in October. The MSCI ...